Interleukin-13 receptor α2 is a novel marker and potential therapeutic target for human melanoma.
Okamoto H, Yoshimatsu Y, Tomizawa T, Kunita A, Takayama R, Morikawa T, Komura D, Takahashi K, Oshima T, Sato M, Komai M, Podyma-Inoue KA, Uchida H, Hamada H, Fujiu K, Ishikawa S, Fukayama M, Fukuhara T, Watabe T.
Okamoto H, et al. Among authors: takahashi k.
Sci Rep. 2019 Feb 4;9(1):1281. doi: 10.1038/s41598-019-39018-3.
Sci Rep. 2019.
PMID: 30718742
Free PMC article.